Impact of vaccination on COVID-19-associated admissions to critical care in England: a population cohort study of linked data

David A Harrison, Peter Watkinson, James Doidge, Manu Shankar‐Hari, Paul Mouncey, Martina Patone, Carol Coupland, Julia Hippisley–Cox, Kathy RowanmedRxiv 2022 · DOI

TL;DR

This population-scale study of 44.7 million adults in England reveals that COVID-19 vaccination provided a massive, sustained shield against critical illness during the Delta wave, with two doses reducing the risk of ICU admission by over 90% across most age groups. While protection began to wane in adults over 70, booster doses effectively restored this "shield" to near-total effectiveness (98.3%).

What Problem Does This Paper Address?

While randomized controlled trials (RCTs) initially proved that vaccines prevent symptomatic COVID-19, those trials often lacked the scale to specifically measure the impact on the rarest and most severe outcome: admission to an Intensive Care Unit (ICU).

As the pandemic progressed into the Delta variant wave, two major questions emerged:

  1. How well do vaccines protect against critical illness in the "real world" across different age groups?
  2. Is the protection "waning" over time, and do boosters actually fix it?

The authors sought to answer these by looking at the entire adult population of England, providing a high-resolution view of who was ending up in critical care and why.

Methods

The researchers conducted a population cohort study using a sophisticated data linkage approach. They merged four major national datasets to track 44.7 million individuals from May 1 to December 15, 2021.

What makes this study robust is the linked data architecture:

  • ICNARC Case Mix Programme: National audit data for almost all adult critical care units.
  • SGSS: National SARS-CoV-2 test results.
  • NIMS: The National Immunisation Management System (vaccination records).
  • ONS: Census data for accurate population denominators.

The team defined "vaccination status" using a 14-day lag (accounting for the time the immune system needs to respond) and calculated the Relative Risk Reduction (RRR)—essentially measuring how much less likely a vaccinated person was to enter the ICU compared to an unvaccinated person of the same age.

Datasets

The study utilized several high-quality, routinely collected UK healthcare datasets:

  • ICNARC (Intensive Care National Audit & Research Centre): Provided data on 10,141 COVID-19 ICU admissions.
  • Second Generation Surveillance System (SGSS): Used for positive PCR/LFD test results.
  • National Immunisation Management System (NIMS): Provided vaccine type, date, and dose.
  • Office for National Statistics (ONS): Provided 2021 census population estimates to ensure the "unvaccinated" denominator was as accurate as possible.

Key Insights and Ideas

  • The "Two Different ICUs" Phenomenon: The profile of a vaccinated ICU patient was fundamentally different from an unvaccinated one. Vaccinated patients were significantly older (median age 64 vs. 50) and far more likely to have severe comorbidities (20.3% vs. 3.9%) or be immunocompromised (15.0% vs. 2.3%).
  • The Pregnancy Factor: A striking finding was that among women aged 18–49 admitted to the ICU, over one-third of the unvaccinated patients were pregnant or recently pregnant. In contrast, virtually no vaccinated pregnant women required critical care.
  • Waning is Age-Specific: Evidence of waning immunity was almost exclusively restricted to the 70+ age group. For those under 70, protection against the ICU remained remarkably stable for 6 to 9 months post-vaccination.
  • The Booster "Reset": In the 70+ group, where protection had dipped to 86.7%, a booster dose pushed the RRR back up to 98.3%, demonstrating the critical role of third doses for the elderly.

Key Results

  • High Baseline Protection: For adults aged 18–69, two doses of any approved vaccine (AstraZeneca, Pfizer, or Moderna) provided an RRR between 90.1% and 95.9%.
  • ICU Overrepresentation: Even as the unvaccinated became a small minority of the general population (dropping from 36% to 10% during the study), they continued to make up the vast majority of ICU admissions (59% overall).
  • Delta Wave Resilience: Despite concerns about the Delta variant's increased severity, the vaccines held firm against critical illness for the vast majority of the population.

Limitations and Future Work

  • Not a Causal Analysis: The authors note that this is an observational study. They cannot rule out "healthy vaccinee" bias—where people who get vaccinated might also be more likely to wear masks or socially distance.
  • Denominator Accuracy: Estimating the exact number of unvaccinated people in a country is notoriously difficult; even small errors in population estimates can skew the results when vaccine uptake is very high.
  • Variant Evolution: This study focused on the Delta wave. Future work is needed to assess if these high levels of protection against critical care admission hold true for Omicron and subsequent sub-variants, which show higher levels of immune escape.

Summary updated

Abstract

Abstract Introduction This study aims to explore the impact of COVID-19 vaccination on critical care by examining associations between vaccination and admission to critical care with COVID-19 during England’s Delta wave, by age group, dose, and over time. Methods We used linked routinely-collected data to conduct a population cohort study of patients admitted to adult critical care in England for management of COVID-19 between 1 May and 15 December 2021. Included participants were the whole population of England aged 18 years or over (44.7 million), including 10,141 patients admitted to critical care with COVID-19. The intervention was vaccination with one, two, or a booster/three doses of any COVID-19 vaccine. Results Compared with unvaccinated patients, vaccinated patients were older (median 64 years for patients receiving two or more doses versus 50 years for unvaccinated), with higher levels of severe comorbidity (20.3% versus 3.9%) and immunocompromise (15.0% versus 2.3%). Compared with patients who were unvaccinated, those vaccinated with two doses had a relative risk reduction (RRR) of between 90.1% (patients aged 18–29, 95% CI, 86.8% to 92.7%) and 95.9% (patients aged 60–69, 95% CI, 95.5% to 96.2%). Waning was only observed for those aged 70+, for whom the RRR reduced from 97.3% (91.0% to 99.2%) to 86.7% (85.3% to 90.1%) between May and December but increased again to 98.3% (97.6% to 98.8%) with a booster/third dose. Conclusion Important demographic and clinical differences exist between vaccinated and unvaccinated patients admitted to critical care with COVID-19. While not a causal analysis, our findings are consistent with a substantial and sustained impact of vaccination on reducing admissions to critical care during England’s Delta wave, with evidence of waning predominantly restricted to those aged 70+.
BibTeX
@misc{harrison2022impact,
  author = {David A Harrison and Peter Watkinson and James Doidge and Manu Shankar‐Hari and Paul Mouncey and Martina Patone and Carol Coupland and Julia Hippisley–Cox and Kathy Rowan},
  title = {{Impact of vaccination on COVID-19-associated admissions to critical care in England: a population cohort study of linked data}},
  year = {2022},
  doi = {10.1101/2022.10.03.22280649},
  howpublished = {medRxiv},
}
Figure